To determine the efficacy and safety of zoledronic acid therapy in the prevention and treatment of postmenopausal osteoporosis compared to placebo or active comparator (other bisphosphonates).
This is a protocol.
Intravenous zoledronate for postmenopausal osteoporosis
You may also be interested in:
- Bisphosphonate therapy for children and adolescents with secondary osteoporosis.
- Etidronate for preventing fractures caused by osteoporosis in postmenopausal women
- Calcitonin for preventing and treating corticosteroid-induced osteoporosis
- Alendronate for preventing fractures caused by osteoporosis in postmenopausal women
- Risedronate for preventing fractures caused by osteoporosis in postmenopausal women
Health topics: